Medtronic Announces Fiscal Year 2022Q2 Financial Results. Net sales for the quarter were $7.847 billion, compared to $7.647 billion in the same period last year, representing a 3% year-over-year increase; net income attributable to the company was $1.311 billion, compared to $489 million in the same period last year, reflecting a 168% year-over-year increase. By business segment, cardiovascular revenue was $2.827 billion, up 3.7% year-over-year; medical surgical revenue was $2.299 billion, up 0.6% year-over-year; neuroscience revenue was $2.136 billion, up 3.5% year-over-year; diabetes revenue was $585 million, up 1.9% year-over-year.
Thermo Fisher Scientific Reports Q3 2021 Financial Results. Quarterly revenue was $9.33 billion, compared to $8.521 billion in the same period last year. Net income for the quarter was $1.902 billion, compared to $1.933 billion in the same period last year. Revenue from the Life Sciences segment was $3.721 billion, compared to $3.424 billion in the same period last year. Revenue from Laboratory Products and Services was $3.487 billion, compared to $3.112 billion in the same period last year. Revenue from Specialty Diagnostics was $1.362 billion, compared to $1.430 billion in the same period last year. Revenue from Analytical Instruments was $1.476 billion, compared to $1.336 billion in the same period last year.
Fresenius Group (Fresenius SE & Co. KGaA) Announces Q3 2021 Results. Quarterly sales reached €9.324 billion (approximately $10.4 billion), a 5% increase year-over-year. Quarterly operating profit (EBIT) was €1.041 billion, down 6% year-over-year. Quarterly net profit was €435 million, up 2% year-over-year. Among the divisions, Fresenius Medical Care reported sales of €4.441 billion, a 1% year-over-year increase. Fresenius Kabi reported sales of €1.854 billion, a 9% year-over-year increase. Fresenius Helios reported sales of €2.622 billion, a 9% year-over-year increase. Fresenius Vamed reported sales of €516 million, remaining flat year-over-year.
Abbott Reports Third-Quarter 2021 Results. Quarterly sales were $10.928 billion, up 23.4% year-over-year; net profit was $2.1 billion, up 70.4% year-over-year. By business segment, medical device revenue was $3.632 billion, up 14.6% year-over-year. Diagnostic business sales were $3.912 billion, up 48.2% year-over-year; of which, global sales related to COVID-19 testing were $1.9 billion. Excluding COVID-19 testing, global diagnostic sales increased 14.1% year-over-year.Danaher Corporation (Danaher) announced its financial results for the third quarter of 2021. Revenue increased by 23.0% year-over-year to reach $7.2 billion. The net income for the quarter was $1.2 billion, representing a year-over-year increase from 2020.Up 33.0%.Johnson & Johnson announced its financial results for the third quarter of 2021. Quarterly sales were $23.338 billion, a year-on-year increase of 10.7%; net profit was $3.667 billion, a year-on-year increase of 3.2%. By business segment, medical device sales were $6.644 billion, an increase of 8.0% year-on-year.
Siemens Healthineers Releases Financial Results for Fiscal Year 2021 (September 30, 2020 to September 30, 2021). Revenue reached a record high of 18 billion euros, representing a year-on-year increase of 19.3% compared to the previous fiscal year impacted by the COVID-19 pandemic. The business of rapid antigen testing for the novel coronavirus contributed 1.1 billion euros in revenue. Since the completion of the acquisition on April 15, 2021, Varian's revenue reached 1.3 billion euros. Revenue for the fourth quarter was 5.164 billion euros (approximately 5.79 billion U.S. dollars), compared to 3.876 billion euros in the same period last year. Net profit for the quarter was 466 million euros, compared to 432 million euros in the same period last year.
BD Reports Fourth Quarter and Full Year Results for Fiscal Year Ended September 30, 2021. Fourth quarter revenue was $5.135 billion, compared to $4.784 billion in the same period last year. Quarterly net profit was $242 million, compared to $105 million in the same period last year. Full year revenue was $20.248 billion, compared to $17.117 billion last year. Annual net profit was $2.002 billion, compared to $767 million last year.Philips Announces Q3 2021 Financial Results. Quarterly sales reached 4.156 billion euros (approximately 4.66 billion US dollars), compared to 4.411 billion euros in the same period last year. Net profit was 2.98 billion euros, compared to 340 million euros in the same period last year. Among this, Diagnostic & Treatment business sales were 2.154 billion euros, Connected Care business sales were 1.044 billion euros, Personal Health business sales were 803 million euros, and other businesses' sales were 153 million euros.Roche announced its financial results for the first three quarters of 2021. In the first nine months, the total sales revenue of the group reached 46.7 billion Swiss francs, compared to 44 billion Swiss francs in the same period last year. Among this, the sales revenue from the diagnostics business was 13.3 billion Swiss francs (approximately 14.25 billion US dollars), compared to 9.7 billion Swiss francs in the same period last year.General Electric (GE) Announces Q3 2021 Earnings. Total revenue for the quarter was $18.429 billion, a year-on-year decrease of 1%. Organic revenue from the industrial segment was $17.6 billion, down 1% year-on-year. By business segment, healthcare revenue was $4.339 billion, a year-on-year decrease of 5%.Medical device and equipment manufacturer Stryker reported its Q3 2021 financial results. Net sales for the quarter were $4.16 billion, compared to $3.737 billion in the same period last year. Quarterly net profit was $438 million, compared to $621 million in the same period last year.Baxter International Inc. Announces Third Quarter 2021 Results. Net sales for the quarter were $3.226 billion, compared to $2.972 billion in the same period last year. Quarterly net income was $450 million, compared to $356 million in the same period last year.Henry Schein Announces Third Quarter 2021 Results. Net sales for the quarter were $3.178 billion, compared to $2.84 billion in the same period last year. Quarterly net profit was $162 million, compared to $142 million in the same period last year.Boston Scientific announced its financial results for the third quarter of 2021. Net sales for the quarter were $2.932 billion, compared to $2.659 billion in the same period last year. The quarterly net profit was $405 million, while the net loss in the same period last year was $169 million.Owens & Minor announced its financial results for the third quarter of 2021. Net revenue for the quarter was $2.502 billion, compared to $2.188 billion in the same period last year. Quarterly net profit was $44.13 million, compared to $46.08 million in the same period last year.3M Reports Third-Quarter 2021 Financial Results. Net sales for the quarter were $8.942 billion, compared to $8.35 billion in the same period last year, representing a 7.1% increase; net income attributable to the company was $1.434 billion, compared to $1.43 billion in the same period last year. By business segment, net sales in the Health Care business were $2.249 billion, an increase of 4.1%.Alcon Announces Third Quarter 2021 Results. Quarterly sales revenue was $2.102 billion, compared to $1.838 billion in the same period last year. Quarterly net profit was $2 million, compared to a net loss of $147 million in the same period last year.Zimmer Biomet Holdings Inc. announced its financial results for the third quarter of 2021. Quarterly sales revenue was $1.924 billion, compared to $1.929 billion in the same period last year. Quarterly net profit was $146 million, compared to $243 million in the same period last year.
Olympus Announces First Half Fiscal Year Results (April 2021 - September 2021). Revenue for the period was 413.059 billion yen (approximately $3.58 billion USD), compared to 316.5 billion yen in the same period last year. Operating profit for the period was 76.256 billion yen, compared to 30.292 billion yen in the same period last year. Net profit for the period was 62.397 billion yen, compared to a net loss of 22.702 billion yen in the same period last year.Terumo Reports First Half Fiscal Year Results (April-September 2021). Revenue for the period was 344.637 billion yen (approximately 3 billion USD), compared to 283.296 billion yen in the same period last year. Operating profit for the period was 65.857 billion yen, compared to 41.824 billion yen last year. Net profit for the period was 49.988 billion yen, compared to 31.842 billion yen last year.Canon's revenue in the third quarter of 2021 increased by 9.8% year-on-year, reaching 833.3 billion yen. The medical business sector's quarterly revenue grew by 9.8% compared to the same period last year, amounting to 115.7 billion yen (approximately 1.37 billion US dollars).Mindray Releases Q3 Report: Revenue for the First Three Quarters of 2021 Reaches 19.392 Billion Yuan, a Year-on-Year Increase of 20.72%; Net Profit Attributable to Shareholders of Listed Companies is 6.663 Billion Yuan, Up 24.23% Year-on-Year; Non-GAAP Net Profit Attributable to Shareholders of Listed Companies is 6.544 Billion Yuan, Increasing by 24.3% Year-on-Year. Mindray's Q3 Revenue is 6.613 Billion Yuan (Approximately 1.035 Billion USD), Growing 20.25% Year-on-Year; Net Profit Attributable to Shareholders of Listed Companies is 2.318 Billion Yuan, Up 21.42% Year-on-Year; Non-GAAP Net Profit Attributable to Shareholders of Listed Companies is 2.235 Billion Yuan, Increasing by 17.7% Year-on-Year. | 
